Tyra Biosciences (TYRA) Research & Development (2020 - 2026)

Tyra Biosciences has reported Research & Development for 7 years, with the latest figure at $33.5 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 34.07% year-over-year to $33.5 million; the trailing twelve-month figure through Mar 2026 stood at $111.4 million (up 26.86% YoY), and the FY2025 full-year result was $102.9 million, up 28.54% from the prior year.
• Research & Development for Q1 2026 stood at $33.5 million, up from $28.2 million in the prior quarter.
• The five-year high for Research & Development was $33.5 million in Q1 2026, with the low at $9.6 million in Q1 2022.
• Historically, Research & Development has averaged $18.9 million across 5 years, with a median of $19.3 million in 2023.
• Annual changes were most pronounced in 2022 — Research & Development surged 174.98% — and 2023, when it climbed 0.95%.
• Tyra Biosciences' Research & Development stood at $10.4 million in 2022, then soared by 98.82% to $20.7 million in 2023, then rose by 7.27% to $22.2 million in 2024, then increased by 27.08% to $28.2 million in 2025, then gained by 18.75% to $33.5 million in 2026.
• The last three Research & Development figures came in at $33.5 million (Q1 2026), $28.2 million (Q4 2025), and $25.5 million (Q3 2025), per Business Quant data.